Safety Profile of Upadacitinib up to 3 Years in Psoriatic Arthritis: An Integrated Analysis of Two Pivotal Phase 3 Trials.

Gerd-Rüdiger R BurmesterKevin WinthropRicardo BlancoPeter NashPhilippe GoupilleValderilio F AzevedoCarlo SalvaraniAndrea Rubbert-RothElizabeth LesserRalph LippeApinya LertratanakulReva M MccaskillJohn LiuEric M Ruderman

Published in: Rheumatology and therapy (2021)

SELECT-PsA 1: NCT03104400; SELECT-PsA 2: NCT03104374.

Keyphrases

prostate cancer
radical prostatectomy